182 related articles for article (PubMed ID: 28701032)
21. Bcl-2 expression and triple negative profile in breast carcinoma.
Kallel-Bayoudh I; Hassen HB; Khabir A; Boujelbene N; Daoud J; Frikha M; Sallemi-Boudawara T; Aifa S; Rebaï A
Med Oncol; 2011 Dec; 28 Suppl 1():S55-61. PubMed ID: 20890735
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of BCL2 in Women Patients with Invasive Breast Cancer.
Ayadi EZ; Cherif B; Ben Hamed Y; Mokni M; Rebai A; Ayadi H; Jlidi R
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3557-3564. PubMed ID: 30583683
[TBL] [Abstract][Full Text] [Related]
23. Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer.
Hwang KT; Kim YA; Kim J; Oh HJ; Park JH; Choi IS; Park JH; Oh S; Chu A; Lee JY; Hwang KR
Sci Rep; 2021 Jun; 11(1):11942. PubMed ID: 34099764
[TBL] [Abstract][Full Text] [Related]
24. Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Park C; Yoon KA; Kim J; Park IH; Park SJ; Kim MK; Jang W; Cho SY; Park B; Kong SY; Lee ES
Cancer Sci; 2019 May; 110(5):1760-1770. PubMed ID: 30811755
[TBL] [Abstract][Full Text] [Related]
25. Prognostic influence of BCL2 expression in breast cancer.
Hwang KT; Woo JW; Shin HC; Kim HS; Ahn SK; Moon HG; Han W; Park IA; Noh DY
Int J Cancer; 2012 Oct; 131(7):E1109-19. PubMed ID: 22418857
[TBL] [Abstract][Full Text] [Related]
26. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
27. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
28. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
29. Survival differences of CIMP subtypes integrated with CNA information in human breast cancer.
Wang H; Yan W; Zhang S; Gu Y; Wang Y; Wei Y; Liu H; Wang F; Wu Q; Zhang Y
Oncotarget; 2017 Jul; 8(30):48807-48819. PubMed ID: 28415743
[TBL] [Abstract][Full Text] [Related]
30. Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer.
Zhao S; Liu XY; Jin X; Ma D; Xiao Y; Shao ZM; Jiang YZ
Theranostics; 2019; 9(17):4935-4945. PubMed ID: 31410192
[No Abstract] [Full Text] [Related]
31. Characterization of β2-microglobulin expression in different types of breast cancer.
Li K; Du H; Lian X; Yang S; Chai D; Wang C; Yang R; Chen X
BMC Cancer; 2014 Oct; 14():750. PubMed ID: 25292288
[TBL] [Abstract][Full Text] [Related]
32. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome.
Aure MR; Vitelli V; Jernström S; Kumar S; Krohn M; Due EU; Haukaas TH; Leivonen SK; Vollan HK; Lüders T; Rødland E; Vaske CJ; Zhao W; Møller EK; Nord S; Giskeødegård GF; Bathen TF; Caldas C; Tramm T; Alsner J; Overgaard J; Geisler J; Bukholm IR; Naume B; Schlichting E; Sauer T; Mills GB; Kåresen R; Mælandsmo GM; Lingjærde OC; Frigessi A; Kristensen VN; Børresen-Dale AL; Sahlberg KK;
Breast Cancer Res; 2017 Mar; 19(1):44. PubMed ID: 28356166
[TBL] [Abstract][Full Text] [Related]
33. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
[TBL] [Abstract][Full Text] [Related]
34. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers.
Natrajan R; Weigelt B; Mackay A; Geyer FC; Grigoriadis A; Tan DS; Jones C; Lord CJ; Vatcheva R; Rodriguez-Pinilla SM; Palacios J; Ashworth A; Reis-Filho JS
Breast Cancer Res Treat; 2010 Jun; 121(3):575-89. PubMed ID: 19688261
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.
Voutsadakis IA
Gene; 2023 Mar; 857():147179. PubMed ID: 36627096
[TBL] [Abstract][Full Text] [Related]
36. Molecular and epigenetic profiles of BRCA1-like hormone-receptor-positive breast tumors identified with development and application of a copy-number-based classifier.
Chen Y; Wang Y; Salas LA; Miller TW; Mark K; Marotti JD; Kettenbach AN; Cheng C; Christensen BC
Breast Cancer Res; 2019 Jan; 21(1):14. PubMed ID: 30683142
[TBL] [Abstract][Full Text] [Related]
37. A DNA methylation-based definition of biologically distinct breast cancer subtypes.
Stefansson OA; Moran S; Gomez A; Sayols S; Arribas-Jorba C; Sandoval J; Hilmarsdottir H; Olafsdottir E; Tryggvadottir L; Jonasson JG; Eyfjord J; Esteller M
Mol Oncol; 2015 Mar; 9(3):555-68. PubMed ID: 25468711
[TBL] [Abstract][Full Text] [Related]
38. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
39. MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes.
Klæstad E; Opdahl S; Engstrøm MJ; Ytterhus B; Wik E; Bofin AM; Valla M
Breast Cancer Res Treat; 2020 Feb; 180(1):73-86. PubMed ID: 31950385
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic and genetic burden measures are associated with tumor characteristics in invasive breast carcinoma.
O'Sullivan DE; Johnson KC; Skinner L; Koestler DC; Christensen BC
Epigenetics; 2016 May; 11(5):344-53. PubMed ID: 27070496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
